Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its ...

Pfizer and Astellas Pharma have received FDA approval for PADCEV, an antibody-drug conjugate, in combination with Keytruda as a neoadjuvant and adjuvant therapy for muscle-invasive bladder cancer in ...

This comes just under a month after Pfizer finalised a deal to acquire Metsera following a bidding war with Novo Nordisk.

Pfizer offers value with a strong dividend, Metsera obesity expansion, PADCEV/Keytruda approval, and an oncology pipeline.

Augments Pfizer’s efforts to advance investigational medicines for cardiometabolic diseasesNEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global ...

Pfizer's expanding oncology portfolio, rising sales of key therapies, and steady pipeline progress reinforce its long-term cancer strategy momentum.

Full US Food and Drug Administration approval of the Pfizer/BioNTech COVID-19 vaccine is "imminent," a senior federal official told CNN on Friday -- but said no date has been mentioned. A person ...

WASHINGTON — The U.S. Food and Drug Administration is expected to give full approval to Pfizer-BioNTech's two-dose coronavirus vaccine as early as Monday, according to multiple reports. Right now, ...